Multicell Technologies Stock

Multicell Technologies Liabilities

The The Liabilities of Multicell Technologies (MCET) as of Jul 29, 2026 is 270,500.00 USD.

Liabilities

270,500.00USD

Last updated:

In 2026, Multicell Technologies's total liabilities amounted to 270,500.00 USD, a % difference from the - USD total liabilities in the previous year.

Access this data via the Eulerpool API

Multicell Technologies Stock analysis

What does Multicell Technologies do? Multicell Technologies Inc is a US-American company specialized in the development and production of innovative products in the field of biomedical and biotechnological research. The company was founded in 1987 by a team of scientists and has held a leading position in the industry ever since. They develop technologies for the isolation and artificial reproduction of cell cultures, collaborate with leading scientists and research institutions to develop new methods and products for fighting diseases such as cancer and cardiovascular diseases, and offer a wide range of products for biomedical and biotechnological research, including cell culture systems, antibody products, and specialized analysis tools. They also work on the production of cell lines and cultures and develop active therapeutics, including a program for developing a new therapeutic for multiple sclerosis. Additionally, they have a diagnostics business and have developed a special platform for DNA sequencing. Overall, Multicell Technologies Inc is known for its close collaboration with the scientific community and its dedication to developing innovative products for the medical field. Multicell Technologies is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Multicell Technologies's Liabilities

Multicell Technologies's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Multicell Technologies's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Multicell Technologies's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Multicell Technologies's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Multicell Technologies’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Multicell Technologies stock

The Liabilities of Multicell Technologies is 270,500.00 USD in 2026.

Access this data via the Eulerpool API

Balance Sheet — Multicell Technologies

All Key Metrics — Multicell Technologies